Cara Therapeutics | 销售和管理费用





销售和管理费用 更改 日
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Assertio Holdings USD 16.73M 1.66M 2024-09
Cara Therapeutics USD 4.64M 2.19M 2025-03
Cassava Sciences USD 7.9M 1.08M 2025-09
Chugai Pharma JPY 36.93B 9.04B 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.33M 50K 2025-09
CSL USD 727M 453M 2025-06
Grifols EUR 333.1M 157M 2025-09
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
J&J USD 6.75B 831M 2025-12
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Pacira USD 91.8M 14.6M 2025-09
Pfizer USD 4.08B 894M 2025-12
RedHill Biopharma USD 4.48M 1.52M 2024-03
Supernus Pharmaceuticals USD 179.68M 117.46M 2025-09
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12


Cara Therapeutics 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.